Roger Tung

Currently holds a position at Concert Pharmaceuticals Inc

Position	Company	Period
President, Chief Executive Officer, Co-Founder, Director	Concert Pharmaceuticals Inc	April 1, 2006 -
Independent Director	Salarius Pharmaceuticals Inc	Oct. 31, 2017 - July 19, 2019

• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings

Download results Settings

Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other

Notification date	Transaction date	Company	B/S Transaction type	Nb. shares Price Value	Number of shares	Price	Value
2023-01-09	2023-01-06	Concert Pharmaceuticals Inc (CNCE)	PlS Planned sale	83,044 +26.3% 390.39 US$3,710,510	83,044 +26.3%	390.39	US$3,710,510
2022-02-16	2022-02-15	Concert Pharmaceuticals Inc (CNCE)	PlS Planned sale	91,989 -10.9% 344.62 US$3,279,194	91,989 -10.9%	344.62	US$3,279,194
2022-01-07	2022-01-06	Concert Pharmaceuticals Inc (CNCE)	PlS Planned sale	23,075 +30.6% 312.59 US$4,062,107	23,075 +30.6%	312.59	US$4,062,107
2021-12-15	2021-12-13	Concert Pharmaceuticals Inc (CNCE)	PlS Planned sale	6,700 -0.8% 3.62 US$24,254	6,700 -0.8%	3.62	US$24,254
2021-02-17	2021-02-17	Concert Pharmaceuticals Inc (CNCE)	PlS Planned sale	13,480 -1.6% 7.20 US$97,056	13,480 -1.6%	7.20	US$97,056